Over the forecast period the Vasopressin for Vasoplegic Shock Market will register a CAGR 15.1 % in terms of revenue and the global Market size will reach USD in 2,967 Million by 2029
Vasopressin for Vasoplegic Shock Market Overview
Vasopressin is an antidiuretic hormone used to treat and prevent postoperative abdominal distention in patients undergoing abdominal roentgenography. It is mostly utilised in intensive care units. Vasopressin infusion improves patients' chances of survival by increasing systemic vascular resistance and arterial pressure. It also reduces the need for catecholamine vasopressors in patients who have or are at risk of developing vasoplegic syndrome following heart surgery. One of the primary reasons driving demand for these medications over the forecast period is the rising number of cardiac procedures throughout the world. Furthermore, the rising global prevalence of sepsis condition is another key driver of the market during the projection period.
In addition, the growing number of pilot programmes and double-blind randomised clinical studies examining the efficacy of vasopressin for vasodilatory shock, as well as the examination of treatment accessibility for cardiogenic shock in the general population, is one of the key drivers of market growth.
What is our Vasopressin for Vasoplegic Shock Market report scope?
|
Report Attributes
|
Report Details
|
|
Forecast Period 2022 to 2029
|
CAGR of 15.1 % during the review period (2022 to 2029).
|
|
By Type
|
- Intravenous Injection
- Intramuscular Injection
- Subcutaneous Injection
|
|
By Application
|
- Sepsis
- Post Cardiac Surgery
- Others
|
|
By Companies
|
- Endo International plc (Dublin, Ireland)
- AMOMED Pharma (Vienna, Austria)
- La Jolla Pharmaceutical Company (California, U.S.)
- Pfizer Inc. (New York, U.S.)
- Ferring Pharmaceuticals (Saint-Prex, Switzerland)
- Fresenius Kabi Canada (Toronto, Canada)
- Astellas Pharma (Tokyo, Japan)
- Eagle Pharmaceuticals, Inc. (New Jersey, U.S.)
- Others
|
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
|
Base Year
|
2021
|
|
Historical Year
|
2017 to 2021
|
|
Forecast Year
|
2022 to 2029
|
|
Number of Pages
|
116
|
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Who are the Major Players in Vasopressin for Vasoplegic Shock Market?
Market Growth Reports lists out all the Vasopressin for Vasoplegic Shock Market companies that are presently striving to reduce the impact of Covid-19 pandemic on the Market- Endo International plc (Dublin, Ireland), AMOMED Pharma (Vienna, Austria), La Jolla Pharmaceutical Company (California, U.S.), Pfizer Inc. (New York, U.S.), Ferring Pharmaceuticals (Saint-Prex, Switzerland), Fresenius Kabi Canada (Toronto, Canada), Astellas Pharma (Tokyo, Japan), Eagle Pharmaceuticals, Inc. (New Jersey, U.S.), Others
Industry News:
Eagle Pharmaceuticals, Inc. announced new drug application
April 2018 - The US Food and Drug Administration (FDA) has approved Eagle Pharmaceuticals, Inc.'s abbreviated new drug application (ANDA) for vasopressin injection, 1ml for submission. This is a generic version of Endo International plc's original Vasostrict formulation, which is used to raise blood pressure in adults who have had vasodilatory shock.
What are the major Applications, Types of Vasopressin for Vasoplegic Shock Market?
By Type, it is segmented into
- Intravenous Injection
- Intramuscular Injection
- Subcutaneous Injection
By Application, it is segmented into
- Sepsis
- Post Cardiac Surgery
- Others
Vasopressin for Vasoplegic Shock Market Regional Analysis
The European market is expected to expand significantly. This is due to the government's significant investments in the R&D sector, which have resulted in the development of highly improved treatment modules for vasoplegic shock. In addition, important firms in the region are putting a lot of effort into developing new therapies for the treatment of vasoplegia. AMOMED Pharma, for example, announced the introduction of a new arginine-vasopressin for catecholamine refractory hypotension in septic shock in COVID 19 patients in April 2020.
- Due to a rising number of manufacturers into the region's undiscovered markets, the Asia Pacific market for vasopressin for vasoplegic shock is expected to rise significantly throughout the projected period.
- Latin America is expected to develop significantly during the projection period as a result of an increasing number of large companies entering uncharted territory.
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
- INTRODUCTION
- MARKET DEFINITION
- MARKET DYNAMICS
- MARKET SEGMENTATION
- REPORT TIMELINES
- KEY STAKEHOLDERS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT MATTER EXPERT ADVICE
- QUALITY CHECK
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- EXECUTIVE SUMMARY
- INTRODUCTION
- GLOBAL VASOPRESSIN FOR VASOPLEGIC SHOCK MARKET BY TYPES
- GLOBAL VASOPRESSIN FOR VASOPLEGIC SHOCK MARKET BY APPLICATIONS
- MARKET DYNAMICS
- DRIVERS
- INCREASING DEMAND FOR MSM SUPPLEMENT
- RESTRAINTS
- STRINGENT ENVIRONMENTAL REGULATIONS
- HIGH COST OF MATERIALS
- OPPORTUNITIES
- VASOPRESSIN FOR VASOPLEGIC SHOCK GROWTH
- APPLICATION OF VASOPRESSIN FOR VASOPLEGIC SHOCK IMPACT OF COVID 19
- GLOBAL VASOPRESSIN FOR VASOPLEGIC SHOCK MARKET, BY TYPE
- INTRAVENOUS INJECTION
- INTRAMUSCULAR INJECTION
- GLOBAL VASOPRESSIN FOR VASOPLEGIC SHOCK MARKET, BY APPLICATION
- SEPSIS
- POST CARDIAC SURGERY
- GLOBAL VASOPRESSIN FOR VASOPLEGIC SHOCK MARKET, BY REGION
- NORTH AMERICA
- EUROPE
- GERMANY
- FRANCE
- UK
- ITALY
- RUSSIA
- REST OF EUROPE
- APAC
- CHINA
- SOUTH KOREA
- JAPAN
- INDIA
- AUSTRALIA
- ASEAN
- REST OF APAC
- MIDDLE EAST AND AFRICA
- SAUDI ARABIA
- UAE
- SOUTH AFRICA
- TURKEY
- REST OF MEA
- SOUTH AMERICA
- BRAZIL
- REST OF MEA
- ARGENTINA
- REST OF SOUTH AMERICA
- COMPETITIVE LANDSCAPE
- MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
- AND AGREEMENTS
- MARKET SHARE PERCENT/RANKING ANALYSIS
- STRATEGIES ADOPTED BY LEADING PLAYERS
- COMPANY PROFILES
- BUSINESS OVERVIEW
- COMPANY SNAPSHOT
- PRODUCT BENCHMARKING
- STRATEGIC INITIATIVES
- ENDO INTERNATIONAL PLC (DUBLIN, IRELAND)
- AMOMED PHARMA (VIENNA, AUSTRIA)
- LA JOLLA PHARMACEUTICAL COMPANY (CALIFORNIA, U.S.)
- PFIZER INC. (NEW YORK, U.S.)
- FERRING PHARMACEUTICALS (SAINT-PREX, SWITZERLAND)
- FRESENIUS KABI CANADA (TORONTO, CANADA)
- ASTELLAS PHARMA (TOKYO, JAPAN)
- EAGLE PHARMACEUTICALS, INC. (NEW JERSEY, U.S.)
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
